The supplement market for PMOS is saturated with products that make bold claims and deliver poor results. This guide tells you exactly which ones have clinical evidence, which mechanisms they target, and which are worth your money.
Take the Free Hormone QuizEvery supplement covered here is assessed by mechanism, clinical evidence, appropriate PMOS phenotype, practical dosing, and bioavailability of form. Products are only recommended where the evidence base is meaningful. Where evidence is limited, that is stated clearly.
The supplements with the strongest evidence in PMOS are myo-inositol (restores insulin signalling in ovarian tissue and improves ovulation), berberine (insulin sensitiser with metformin-comparable effects), magnesium (essential cofactor for insulin receptor function and cortisol metabolism), zinc (reduces androgen activity and supports follicle maturation), omega-3 fatty acids EPA and DHA (reduces systemic inflammation and triglycerides), and vitamin D (directly influences insulin signalling and ovarian function). These form the evidence-based foundation. Everything else builds on top of this base, guided by your specific PMOS type and test results.
Three structural problems account for the majority of supplement protocol failures in PMOS.
PMOS has four distinct clinical subtypes: insulin-driven, adrenal-driven, inflammatory, and post-pill. A supplement that powerfully addresses insulin-driven PMOS (myo-inositol, berberine) may produce minimal results in a woman whose primary driver is adrenal androgen excess. A woman with post-pill PMOS needs nutritional restoration of the vitamins and minerals depleted by long-term oral contraceptive use, not necessarily an insulin sensitiser. Matching the supplement to the PMOS type is the most important variable in determining outcome.
Nutrient form determines bioavailability. Magnesium oxide, one of the most common forms in budget supplements, has approximately 4 percent bioavailability compared to magnesium glycinate at 80 percent or more. Zinc oxide is significantly less absorbable than zinc picolinate or glycinate. Vitamin D2 is less effective than D3 at raising serum 25-OH vitamin D levels. Taking the right nutrient in the wrong form frequently produces no measurable effect on blood levels and leads women to conclude the supplement does not work, when the problem is the formulation.
No supplement corrects a dietary pattern that keeps insulin chronically elevated, or compensates for the cortisol-driven androgen amplification of unmanaged chronic stress. Supplements amplify the effects of a well-structured dietary and lifestyle foundation. They do not replace it. Women who take supplements without the dietary and lifestyle changes described in our PMOS diet guide consistently report poorer outcomes than those who combine both.
“The two questions I ask before recommending any supplement are: what is the mechanism, and what is the evidence? A supplement without a clear mechanism is a guess. A mechanism without clinical evidence is a hypothesis. In PMOS, we have enough genuinely evidence-supported options that there is no need to rely on either. What we also have is a deeply individual condition, which is why the same supplement at the same dose produces dramatically different results in different women. The supplement protocol must follow the clinical picture, not precede it.”Dr Olwethu Sotondoshe | Natural Hormone Health Practitioner & Homeopath | Ask Dr Olz
| Supplement | Primary Mechanism in PMOS | Best PMOS Type | Evidence Level |
|---|---|---|---|
| Myo-inositol | Restores insulin signalling in ovarian tissue; improves LH/FSH ratio; promotes ovulation | Insulin-driven (Type 1) | Strong |
| Berberine | AMPK activation; reduces hepatic glucose output; comparable to metformin in insulin sensitisation | Insulin-driven (Type 1) | Strong |
| Magnesium | Insulin receptor cofactor; cortisol metabolism; GABA modulation; sleep support | All types | Strong |
| Zinc | 5-alpha reductase inhibition; insulin sensitivity; follicle maturation; anti-inflammatory | All types, especially androgenic | Strong |
| Omega-3 EPA/DHA | Reduces systemic inflammation; lowers triglycerides; improves insulin sensitivity; supports mood | All types, especially inflammatory (Type 3) | Strong |
| Vitamin D3 | Insulin receptor expression; ovarian follicle function; reduces anti-Müllerian hormone in excess | All types | Strong |
| N-Acetyl Cysteine (NAC) | Glutathione precursor; anti-inflammatory; insulin sensitisation; comparable to metformin in some trials | Inflammatory (Type 3); insulin-driven | Good |
| Chromium | Enhances insulin receptor sensitivity; reduces carbohydrate cravings | Insulin-driven (Type 1) | Good |
| Spearmint tea / extract | Anti-androgenic via 5-alpha reductase inhibition; reduces free testosterone | Androgenic (acne, hirsutism) | Good |
| DIM (diindolylmethane) | Promotes 2-OH oestrogen metabolites; supports androgen clearance through liver | Oestrogen-dominant; inflammatory | Good |
| Chasteberry (Vitex) | Dopamine agonist; reduces LH excess; supports progesterone production | LH-dominant; post-pill; progesterone-deficient | Good |
| Ashwagandha | HPA axis modulation; reduces cortisol; adrenal support; improves thyroid conversion | Adrenal-driven (Type 2); stress-aggravated | Good |
| Sulforaphane | Nrf2 activation; Phase 2 liver detoxification; anti-inflammatory; androgen clearance | Inflammatory (Type 3) | Emerging |
| Cinnamon | Insulin mimetic; slows gastric emptying; reduces post-meal glucose spike | Insulin-driven; blood sugar instability | Emerging |
| Saw palmetto | 5-alpha reductase inhibitor; reduces DHT from testosterone | Androgenic (hair loss, hirsutism) | Traditional |
These six supplements have the most robust clinical evidence in PMOS and should form the foundation of any protocol before more targeted additions are considered.
Inositol is a naturally occurring compound involved in insulin signal transduction. Myo-inositol acts as a second messenger for insulin in ovarian tissue, directly restoring the insulin signalling defect that drives androgen excess and anovulation in PMOS. Multiple randomised controlled trials have demonstrated that myo-inositol (2000mg twice daily) improves ovulation rates, reduces fasting insulin, lowers free testosterone, improves egg quality, and reduces the LH/FSH ratio, the hormonal fingerprint of PMOS. When combined with D-chiro-inositol in a 40:1 ratio (mimicking the physiological ratio), effects on androgen reduction are further amplified. This is the most evidence-supported single supplement intervention in PMOS.
The clinical effect on ovulation restoration is comparable to clomiphene (the conventional ovulation induction medication) in women with insulin-driven PMOS, making it a first-line consideration for women seeking to restore natural ovulation without pharmaceutical intervention.
Typical dose: 2000mg myo-inositol twice daily with meals. Results typically appear at three to six months.Berberine is an alkaloid derived from several plants including barberry and goldenseal. It activates AMPK (AMP-activated protein kinase), the same enzyme pathway targeted by metformin, producing comparable insulin-sensitising effects. Head-to-head clinical trials comparing berberine to metformin in PMOS have found equivalent reductions in fasting insulin, free testosterone, LH/FSH ratio, and BMI, with berberine producing slightly better lipid outcomes in some studies.
In the South African context, where metformin access requires a prescription and ongoing monitoring, berberine offers a practitioner-accessible insulin-sensitising option with strong clinical data. It is also better tolerated gastrointestinally than metformin in many women. Note that berberine has several drug interactions including with certain antibiotics and blood-thinning medications, and should be taken with practitioner guidance if other medications are in use.
Typical dose: 500mg three times daily with meals. Should be cycled (eight weeks on, two weeks off) in longer-term use. Not for use in pregnancy.Magnesium is a required cofactor in over 300 enzymatic reactions, including insulin receptor phosphorylation, glucose transporter activation, and cortisol metabolism. Deficiency is almost universal in PMOS, worsened by chronic stress (stress depletes magnesium rapidly), refined-carbohydrate-heavy diets (low in magnesium), and chronic cortisol elevation (increases urinary magnesium excretion). Women with PMOS consistently show lower serum magnesium than controls, and correction of deficiency produces meaningful improvements in fasting insulin, cortisol response, sleep quality, and PMS symptom severity.
Glycinate is the most bioavailable and best-tolerated form for systemic use. Oxide forms found in budget supplements have approximately 4 percent bioavailability and are primarily useful only as stool softeners. Taken at night, magnesium glycinate additionally supports GABA activity and sleep quality, addressing two common PMOS complaints simultaneously.
Typical dose: 300 to 400mg elemental magnesium as glycinate, taken at night. Start lower if digestive sensitivity is present.Zinc is essential for 5-alpha reductase inhibition (the enzyme that converts testosterone to the more potent DHT, driving acne and hair loss), insulin receptor sensitivity, progesterone synthesis after ovulation, and follicle maturation. Women with PMOS consistently show lower serum zinc than controls. Zinc supplementation in clinical trials has demonstrated reductions in free testosterone, improved fasting insulin, reduction in hirsutism scores, and improved ovarian function markers.
The form of zinc matters significantly. Zinc oxide, the form in the majority of budget supplements and many multivitamins, has very low bioavailability. Zinc glycinate and zinc picolinate are significantly better absorbed and produce measurable increases in serum zinc at lower doses.
Typical dose: 25 to 30mg elemental zinc as glycinate or picolinate daily with food. Take away from calcium supplements, which reduce absorption.EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) are the active forms of omega-3 that produce anti-inflammatory effects in the body. South African diets are typically heavily omega-6 dominant due to widespread use of refined sunflower oil, creating a pro-inflammatory omega-6 to omega-3 ratio. In PMOS, systemic inflammation maintains insulin resistance and drives ovarian androgen production. Multiple clinical trials in PMOS have demonstrated that high-dose EPA and DHA reduce triglycerides (elevated in most PMOS women), lower free testosterone, reduce inflammatory markers including CRP, and improve insulin sensitivity. EPA specifically has the strongest anti-inflammatory evidence and antidepressant efficacy, relevant for the mood symptoms common in PMOS.
Dose matters in omega-3 supplementation. Low-dose fish oil capsules (typical 300mg EPA+DHA per capsule) require very high numbers of capsules to reach therapeutic anti-inflammatory doses. High-potency formulations providing 1000mg or more of combined EPA+DHA per serving are significantly more practical and cost-effective.
Therapeutic dose for PMOS: 2000 to 3000mg combined EPA+DHA daily. Take with food to improve absorption and reduce aftertaste.Vitamin D deficiency is strongly associated with PMOS severity. Women with PMOS have significantly higher rates of vitamin D deficiency than the general population, and correction of deficiency produces measurable improvements in fasting insulin, menstrual regularity, and inflammatory markers. Vitamin D receptors are expressed in ovarian granulosa cells and directly influence follicle maturation. Vitamin D also modulates the immune response relevant to autoimmune thyroid disease, which co-occurs with PMOS at elevated rates.
Despite South Africa’s sunshine, vitamin D deficiency is common due to indoor lifestyles, consistent sun protection, and the fact that melanin in darker skin reduces UV-driven vitamin D synthesis at a given sun exposure. Testing 25-OH vitamin D before supplementing is ideal to establish baseline and guide dosing. The functional optimal range for PMOS is 100 to 150 nmol/L, considerably above the basic sufficiency threshold of 50 nmol/L used in standard reference ranges.
Typical maintenance dose: 2000 to 4000 IU vitamin D3 daily with a fat-containing meal. Higher doses may be needed to correct deficiency. Take with vitamin K2 for optimal tissue delivery.These supplements have meaningful clinical evidence in PMOS and are added to the Tier 1 foundation based on your specific symptom picture and PMOS type.
Chasteberry (Vitex agnus-castus) acts as a dopamine agonist on the pituitary, reducing excess LH secretion. Elevated LH relative to FSH is a hallmark of PMOS and drives ovarian androgen excess. Vitex also supports progesterone production in the luteal phase. Clinical trials show improved cycle regularity, reduced PMS, and improved progesterone levels in women with LH excess and luteal phase deficiency. Best suited to post-pill PMOS and women with confirmed LH dominance. Use with caution if already using hormonal contraception or fertility medications.
View Chasteberry Plus on Ask Dr OlzContains DIM (diindolylmethane), calcium D-glucarate, and supporting B vitamins. DIM promotes the shift from proliferative 16-OH oestrogen metabolites toward protective 2-OH metabolites and also reduces androgen activity through the liver. Calcium D-glucarate inhibits beta-glucuronidase, reducing oestrogen and androgen reabsorption from the gut. Particularly relevant for PMOS presentations with co-existing oestrogen dominance (heavy periods, breast tenderness, bloating alongside androgenic symptoms).
View EstroFactors on Ask Dr OlzIndole-3-carbinol is the precursor to DIM, derived from cruciferous vegetables. It supports Phase 1 liver oestrogen and androgen metabolism, promoting healthy clearance of excess androgens. Useful for women with prominent acne, hirsutism, or hair loss where androgen clearance through the liver is a primary target.
View Meta I 3 C on Ask Dr OlzAdaptogenic formula containing rhodiola, eleuthero, and cordyceps. Supports adrenal resilience and cortisol rhythm normalisation. First priority for women with adrenal-driven PMOS (Type 2) where DHEA-S is elevated, or for any PMOS presentation significantly aggravated by stress. Reduces the cortisol-DHEA-androgen amplification pathway that operates independently of ovarian androgen production.
View Adreset on Ask Dr OlzBroad adaptogenic formula combining ashwagandha, rhodiola, and holy basil. Ashwagandha specifically has clinical evidence for reducing cortisol, supporting thyroid T4-to-T3 conversion, and improving stress-driven hormonal disruption. Particularly suited to women whose PMOS symptoms clearly worsen under periods of high stress and whose energy and mood are significantly affected.
View Exhilarin on Ask Dr OlzComprehensive blood sugar metabolism support combining multiple evidence-based nutrients and botanical extracts that address post-meal glucose spikes, fasting insulin, and insulin receptor sensitivity through complementary mechanisms. A practical all-in-one addition to a PMOS protocol where multiple insulin-supporting nutrients are needed without taking several separate supplements.
View MetaGlycemX on Ask Dr OlzL-carnitine is required for fatty acid transport into mitochondria for energy production. Several clinical trials in PMOS have shown that L-carnitine supplementation reduces fasting insulin, improves lipid profiles, and supports weight loss alongside lifestyle changes. Particularly relevant for women with significant metabolic sluggishness and fatigue alongside insulin resistance.
View L-Carnitine on Ask Dr OlzRestores gut microbiome diversity consistently reduced in PMOS. Improved gut flora directly improves insulin sensitivity, reduces inflammatory cytokines, and supports androgen metabolism through the gut-hormone axis. Daily probiotic support is particularly important during and after dietary transition, when the microbiome is shifting toward a less inflammatory composition.
View UltraFlora Balance on Ask Dr OlzConcentrated sulforaphane activates Nrf2, the master regulator of cellular antioxidant defence. Reduces systemic inflammatory markers, supports Phase 2 liver detoxification of androgens and oestrogen metabolites, and has emerging evidence for improving insulin sensitivity through inflammatory pathway modulation. First priority for inflammatory-type PMOS (Type 3).
View SulforaClear on Ask Dr OlzGlutathione is the body’s master antioxidant and is central to liver Phase 2 detoxification. Women with PMOS show reduced glutathione levels compared to controls. Glutathione support reduces oxidative stress (elevated in PMOS), supports liver androgen clearance, and reduces the inflammatory burden that maintains insulin resistance.
View GlutaClear on Ask Dr OlzThese supplements have meaningful evidence for specific PMOS presentations and are added when the clinical picture points clearly to their mechanism.
Provides iodine, selenium, zinc, and supporting nutrients for thyroid hormone production and T4-to-T3 conversion. Thyroid dysfunction co-occurs with PMOS at elevated rates and is frequently missed on TSH-only testing. Sub-optimal thyroid function worsens insulin resistance, reduces metabolic rate, and aggravates weight resistance in PMOS. Use only when full thyroid panel (including free T3 and anti-TPO) has been assessed.
View Thyrosol on Ask Dr OlzComprehensive liver Phase 1 and Phase 2 support. Indicated for women with PMOS where androgen and oestrogen clearance is a primary clinical target, particularly those with prominent acne, hirsutism, heavy irregular periods alongside androgenic features, or known liver enzyme elevation. Enhances the liver’s capacity to process and excrete excess steroid hormones.
View AdvaClear on Ask Dr OlzComprehensive B vitamin complex in active forms. B vitamins are depleted by long-term oral contraceptive use (common in post-pill PMOS), by chronic stress, and by refined-carbohydrate-heavy diets. B6 is specifically required for progesterone synthesis and dopamine production. B12 and folate support methylation, which governs oestrogen and androgen metabolism. Active forms (methylcobalamin, methylfolate, pyridoxal-5-phosphate) bypass genetic variation in conversion efficiency.
View Glycogenics B-Complex on Ask Dr OlzTargeted methylation support with methylcobalamin, methylfolate, and supporting cofactors. Elevated homocysteine is more common in PMOS and is associated with cardiovascular risk and impaired hormone metabolism. Methylation support is particularly relevant for women with PMOS and confirmed MTHFR polymorphisms, thyroid autoimmunity, or elevated homocysteine on testing.
View MethylCare on Ask Dr OlzPre-formulated “hormonal balance” or “PCOS support” blends typically contain low doses of several ingredients, each at a dose too small to produce the clinical effect demonstrated in research. A product containing 50mg of myo-inositol is not comparable to the 2000mg twice-daily dose used in clinical trials. These blends tend to contain many ingredients at sub-therapeutic doses rather than fewer ingredients at evidence-based doses. They also cannot be adjusted to match different PMOS types.
Evening primrose oil contains gamma-linolenic acid (GLA) and is widely recommended in natural health circles for PMOS. Clinical evidence for meaningful PMOS benefit is weak. It is not an insulin sensitiser, does not lower androgens, and does not restore ovulation in clinical trials. It may have a minor role in reducing prostaglandin-driven dysmenorrhoea but is not a PMOS-specific treatment.
High-dose biotin does not improve PMOS symptoms in the absence of deficiency. It also interferes with several thyroid blood test assays, producing falsely elevated thyroid hormone levels that can lead to incorrect clinical decisions. Women taking high-dose biotin supplements should inform their practitioner and ideally pause supplementation 48 to 72 hours before thyroid blood testing.
Collagen supplements improve skin, hair, and joint health through amino acid provision but have no direct mechanism for addressing insulin resistance, androgen excess, or ovulation dysfunction. They are not a PMOS treatment.
Important: Supplements are not regulated as strictly as pharmaceutical drugs in South Africa. Product quality, ingredient purity, and actual dose delivered can vary significantly between manufacturers. Professional-grade supplements from reputable suppliers undergo third-party testing and use standardised ingredients. This is one of the most important reasons to source PMOS supplements through a practitioner or a verified professional-grade supplier rather than a general pharmacy or online marketplace.
Foundation: myo-inositol + berberine + magnesium glycinate + zinc glycinate + vitamin D3 + omega-3 EPA/DHA. Add MetaGlycemX for comprehensive blood sugar support. Add UltraFlora Balance for gut-insulin axis. Add L-carnitine if significant metabolic sluggishness or weight resistance is present.
Foundation: magnesium glycinate + zinc glycinate + vitamin D3 + omega-3 EPA/DHA. Add Adreset or Exhilarin as primary adaptogenic support. Add Glycogenics B-Complex for adrenal nutritional support. Add myo-inositol if insulin resistance is also present. Add Thyrosol if thyroid conversion is sub-optimal on testing.
Foundation: omega-3 EPA/DHA (higher dose, 3000mg combined EPA+DHA) + magnesium glycinate + zinc glycinate + vitamin D3. Add SulforaClear for Nrf2 activation and liver detox. Add UltraFlora Balance for gut-inflammation axis. Add GlutaClear for oxidative stress reduction. Add EstroFactors if androgen and oestrogen clearance is a co-target.
Foundation: Glycogenics B-Complex (restores pill-depleted B vitamins) + zinc glycinate + magnesium glycinate + vitamin D3 + omega-3 EPA/DHA. Add Chasteberry Plus to support LH normalisation and progesterone restoration after pill cessation. Add UltraFlora Balance to restore gut microbiome. Add myo-inositol if insulin resistance is present on testing.
Book a telehealth consultation with Dr Olwethu Sotondoshe for comprehensive PMOS testing and a personalised, evidence-based supplement protocol matched to your specific PMOS type, test results, and symptom picture.
Start With the Free Hormone QuizThere is no single best supplement because PMOS has four distinct subtypes with different primary drivers. However, if one supplement had to be named as the most broadly evidence-supported in PMOS, it would be myo-inositol, which directly addresses the ovarian insulin signalling defect present in the majority of PMOS cases and has the most robust clinical trial data for restoring ovulation, reducing androgens, and improving insulin sensitivity. Combined with magnesium glycinate, zinc glycinate, and vitamin D3, these four form the most impactful foundation for the greatest number of PMOS women.
They work through different mechanisms and target different aspects of insulin dysregulation in PMOS. Myo-inositol restores insulin signalling specifically in ovarian tissue and has the strongest evidence for improving ovulation and reducing LH/FSH ratio. Berberine acts more broadly as a systemic insulin sensitiser with effects comparable to metformin and stronger evidence for weight management and lipid improvement. For women prioritising ovulation restoration, myo-inositol is first choice. For women with significant insulin resistance across multiple metabolic markers, berberine may be more impactful. Many integrative protocols use both together for synergistic effect.
Timeline varies by symptom and supplement. Energy and mood improvements from magnesium and B vitamins are often noticeable within two to four weeks. Fasting insulin reduction from myo-inositol and berberine typically appears at four to eight weeks of consistent use. Skin changes (reduced acne) reflect slower androgen reduction and typically appear at six to twelve weeks. Cycle regularity improvement, which reflects the most fundamental hormonal restoration, typically requires three to six months of consistent supplementation alongside dietary and lifestyle change. All timelines are accelerated when supplements are combined with appropriate dietary changes rather than used in isolation.
Myo-inositol is considered safe in preconception and has been used in fertility protocols. Berberine is contraindicated in pregnancy and should be stopped when actively trying to conceive or when pregnancy is confirmed. Vitamin D3, magnesium, zinc, and folate are all recommended in preconception. Adaptogenic herbs including ashwagandha and chasteberry should be stopped once pregnancy is confirmed. Always discuss all supplements with a qualified healthcare practitioner before and during pregnancy.
Not necessarily. Many women with PMOS achieve a state of hormonal and metabolic balance after six to twelve months of consistent supplementation alongside dietary and lifestyle changes, at which point the supplement load can often be reduced to a maintenance level. The foundational nutrients, magnesium, zinc, vitamin D, and omega-3, are often worth maintaining long-term given their broad health benefits and the ongoing depletion pressures of modern South African life. Condition-specific supplements like myo-inositol and berberine can often be tapered once fasting insulin and androgen markers have normalised and symptoms have resolved.